
Novartis Shaves Six Months Off Trial Enrollment
Novartis’s Intelligent Decision System runs thousands of trial-planning simulations in minutes, with executives reporting 50% more accurate enrollment forecasts than its previous process.
PharmaCompany

Novartis has improved its trial enrollment process by implementing its Intelligent Decision System, which conducts thousands of trial-planning simulations in minutes. This advancement has resulted in a six-month reduction in trial enrollment time and a 50% increase in the accuracy of enrollment forecasts.
+1 in the last 30 days
1 live
Latest tracker entry
live50% enrollment forecast accuracy
trial planning




MachineCon USA · from AIM Media House
An invitation-led day for the CIOs, CDOs and Chief AI Officers who own enterprise AI strategy.



